1.75 semaglutide FDA approves obesity drug that helped people cut weight 15% 1) receptor antagonist and works by slowing down digestion Wegovy (semaglutide) Injector 1.7 mg/0.75

Tirzepatide does not directly affect menstrual cycles, but the significant weight loss it produces can alter reproductive hormone balance, potentially causing irregular bleeding or changes in cycle patterns, especially in women with PCOS

2018;7 doi: 10.1002/adhm.201701503

Assess for pain, laxity, and crepitus, indicating a positive test

It's worth noting that Ozempic is licensed for type 2 diabetes, while Wegovy (also semaglutide, but at higher doses) is the UK-licensed product specifically for weight management

Citterio CE, Targovnik HM, Arvan P (2019) The role of thyroglobulin in thyroid hormonogenesis

Bizino MB, Jazet IM, De Heer P, Van Eyk HJ, Dekkers IA, Rensen PCN, et al